SEOM-GEMCAD-TTD clinical guideline for the diagnosis and treatment of esophageal cancer (update 2025)

Esophageal cancer represents an aggressive disease positioned as the seventh-leading cause of death from cancer. Esophageal cancer comprises two different diseases that should be distinguished by histology, i.e., squamous cell carcinoma and adenocarcinoma. The epidemiology and molecular differences...

Descripción completa

Detalles Bibliográficos
Autores: Fernández-Montes, A, Alcaide, J, Custodio, AB, Franco, LF, Plazas, JG, Gómez-Martín, C, Richart, P, Rivera, F, Alsina, M
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2026
País:España
Institución:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Repositorio:r-FISABIO. Repositorio Institucional de Producción Científica
OAI Identifier:oai:dnet:r-fisabio___::42bd4ddf4f809715c52974f573193e5a
Acceso en línea:https://fisabio.portalinvestigacion.com/publicaciones/20572
Access Level:acceso abierto
Palabra clave:Esophageal cancer
Squamous cell carcinoma
Adenocarcinoma
Diagnosis
Treatment
id ES_bd39ba8ebfec59af4bb1fd16dbfaa8af
oai_identifier_str oai:dnet:r-fisabio___::42bd4ddf4f809715c52974f573193e5a
network_acronym_str ES
network_name_str España
repository_id_str
spelling SEOM-GEMCAD-TTD clinical guideline for the diagnosis and treatment of esophageal cancer (update 2025)Fernández-Montes, AAlcaide, JCustodio, ABFranco, LFPlazas, JGGómez-Martín, CRichart, PRivera, FAlsina, MEsophageal cancerSquamous cell carcinomaAdenocarcinomaDiagnosisTreatmentEsophageal cancer represents an aggressive disease positioned as the seventh-leading cause of death from cancer. Esophageal cancer comprises two different diseases that should be distinguished by histology, i.e., squamous cell carcinoma and adenocarcinoma. The epidemiology and molecular differences between these two entities explain their different responsiveness to novel treatments which should be treated independently. The improvement in outcomes of patients with esophageal cancer are obtained when a multidisciplinary therapeutic strategy is utilized. The introduction of targeted therapies including immunotherapy has markedly improved patient outcomes. We present an updated version of the Spanish esophageal cancer guidelines, summarizing the current evidence and available therapies for the treatment of esophageal cancer.SPRINGER INT PUBL AG2026info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://fisabio.portalinvestigacion.com/publicaciones/20572Clinical & Translational OncologyISSN: 1699048XISSNe: 16993055reponame:r-FISABIO. Repositorio Institucional de Producción Científicainstname:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)Inglésinfo:eu-repo/semantics/openAccessoai:dnet:r-fisabio___::42bd4ddf4f809715c52974f573193e5a2026-06-11T12:45:17Z
dc.title.none.fl_str_mv SEOM-GEMCAD-TTD clinical guideline for the diagnosis and treatment of esophageal cancer (update 2025)
title SEOM-GEMCAD-TTD clinical guideline for the diagnosis and treatment of esophageal cancer (update 2025)
spellingShingle SEOM-GEMCAD-TTD clinical guideline for the diagnosis and treatment of esophageal cancer (update 2025)
Fernández-Montes, A
Esophageal cancer
Squamous cell carcinoma
Adenocarcinoma
Diagnosis
Treatment
title_short SEOM-GEMCAD-TTD clinical guideline for the diagnosis and treatment of esophageal cancer (update 2025)
title_full SEOM-GEMCAD-TTD clinical guideline for the diagnosis and treatment of esophageal cancer (update 2025)
title_fullStr SEOM-GEMCAD-TTD clinical guideline for the diagnosis and treatment of esophageal cancer (update 2025)
title_full_unstemmed SEOM-GEMCAD-TTD clinical guideline for the diagnosis and treatment of esophageal cancer (update 2025)
title_sort SEOM-GEMCAD-TTD clinical guideline for the diagnosis and treatment of esophageal cancer (update 2025)
dc.creator.none.fl_str_mv Fernández-Montes, A
Alcaide, J
Custodio, AB
Franco, LF
Plazas, JG
Gómez-Martín, C
Richart, P
Rivera, F
Alsina, M
author Fernández-Montes, A
author_facet Fernández-Montes, A
Alcaide, J
Custodio, AB
Franco, LF
Plazas, JG
Gómez-Martín, C
Richart, P
Rivera, F
Alsina, M
author_role author
author2 Alcaide, J
Custodio, AB
Franco, LF
Plazas, JG
Gómez-Martín, C
Richart, P
Rivera, F
Alsina, M
author2_role author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Esophageal cancer
Squamous cell carcinoma
Adenocarcinoma
Diagnosis
Treatment
topic Esophageal cancer
Squamous cell carcinoma
Adenocarcinoma
Diagnosis
Treatment
description Esophageal cancer represents an aggressive disease positioned as the seventh-leading cause of death from cancer. Esophageal cancer comprises two different diseases that should be distinguished by histology, i.e., squamous cell carcinoma and adenocarcinoma. The epidemiology and molecular differences between these two entities explain their different responsiveness to novel treatments which should be treated independently. The improvement in outcomes of patients with esophageal cancer are obtained when a multidisciplinary therapeutic strategy is utilized. The introduction of targeted therapies including immunotherapy has markedly improved patient outcomes. We present an updated version of the Spanish esophageal cancer guidelines, summarizing the current evidence and available therapies for the treatment of esophageal cancer.
publishDate 2026
dc.date.none.fl_str_mv 2026
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://fisabio.portalinvestigacion.com/publicaciones/20572
url https://fisabio.portalinvestigacion.com/publicaciones/20572
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv SPRINGER INT PUBL AG
publisher.none.fl_str_mv SPRINGER INT PUBL AG
dc.source.none.fl_str_mv Clinical & Translational Oncology
ISSN: 1699048X
ISSNe: 16993055
reponame:r-FISABIO. Repositorio Institucional de Producción Científica
instname:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
instname_str Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
reponame_str r-FISABIO. Repositorio Institucional de Producción Científica
collection r-FISABIO. Repositorio Institucional de Producción Científica
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869418182957072384
score 15.812429

Similares en LA Referencia